Welcome to LookChem.com Sign In|Join Free

CAS

  • or

541-16-2

Post Buying Request

541-16-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

541-16-2 Usage

Description

Di-tert-Butyl malonate is a clear colorless to slightly yellow liquid that serves as a versatile reagent and intermediate in various chemical and pharmaceutical applications. It is known for its stability and ability to participate in a range of reactions, making it a valuable compound in the synthesis of various organic molecules.

Uses

1. Used in Pharmaceutical Industry:
Di-tert-Butyl malonate is used as a pharmaceutical intermediate for the synthesis of various drugs and active pharmaceutical ingredients. Its stability and reactivity make it a preferred choice in the development of new medications.
2. Used in Chemical Synthesis:
Di-tert-Butyl malonate is used in the preparation of ketones, which are essential building blocks in the synthesis of a wide range of organic compounds, including pharmaceuticals, agrochemicals, and specialty chemicals.
3. Used in Diazomalonsaeure-di-tert-butylester Production:
Di-tert-Butyl malonate is used to produce Diazomalonsaeure-di-tert-butylester at ambient temperature. This process requires reagents such as cesium carbonate, p-toluenesulfonyl azide, and the solvent tetrahydrofuran, with a reaction time of 1 hour.
4. Used in Total Synthesis of (+/?)-Actinophyllic Acid:
Di-tert-Butyl malonate is employed as a precursor in the total synthesis of (+/?)-actinophyllic acid, a naturally occurring compound with potential biological activities.
5. Used in Metal-Organic Chemical Vapor Deposition (MOCVD) of HfO2 and ZrO2 Thin Films:
Di-tert-Butyl malonate is utilized as a precursor in the MOCVD process for the deposition of HfO2 and ZrO2 thin films, which are essential materials in the semiconductor industry for the fabrication of advanced electronic devices.

Check Digit Verification of cas no

The CAS Registry Mumber 541-16-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,4 and 1 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 541-16:
(5*5)+(4*4)+(3*1)+(2*1)+(1*6)=52
52 % 10 = 2
So 541-16-2 is a valid CAS Registry Number.
InChI:InChI=1/C11H20O4/c1-10(2,3)14-8(12)7-9(13)15-11(4,5)6/h7H2,1-6H3

541-16-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A12774)  Di-tert-butyl malonate, 98+%, stab. with potassium carbonate   

  • 541-16-2

  • 10g

  • 577.0CNY

  • Detail
  • Alfa Aesar

  • (A12774)  Di-tert-butyl malonate, 98+%, stab. with potassium carbonate   

  • 541-16-2

  • 50g

  • 2337.0CNY

  • Detail
  • Alfa Aesar

  • (A12774)  Di-tert-butyl malonate, 98+%, stab. with potassium carbonate   

  • 541-16-2

  • 250g

  • 9296.0CNY

  • Detail

541-16-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Di-tert-Butyl malonate

1.2 Other means of identification

Product number -
Other names Di-tert-Butyl malona

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:541-16-2 SDS

541-16-2Relevant articles and documents

Methanofullerene Molecular Scaffolding: Towards C60-Substituted Poly(triacetylenes) and Expanded Radialenes, Preparation of a C60-C70 Hybrid Derivative, and a Novel Macrocyclization Reaction

Nierengarten, Jean-Francois,Herrmann, Andreas,Tykwinski, Rik R.,Ruettimann, Markus,Diederich, Francois,Boudon, Corinne,Gisselbrecht, Jean-Paul,Gross, Maurice

, p. 293 - 316 (1997)

The synthesis of (E)-hex-3-ene-1,5-diynes and 3-methylidenepenta-1,4-diynes with pendant methano[60]-fullerene moieties as precursors to C60-substituted poly(triacetylenes) (PTAs, Fig. 1) and expanded radialenes (Fig. 2) is described. The Bingel reaction of diethyl (E)-2,3-dialkynylbut-2-ene-1,4-diyl bis(2-bromopropanedioates) 5 and 6 with two C60 molecules (Scheme 2) afforded the monomeric, silyl-protected PTA precursors 9 and 10 which, however, could not be effectively desilylated (Scheme 4). Also formed during the synthesis of 9 and 10, as well as during the reaction of C60 with the desilylated analogue 16 (Scheme 5), were the macrocyclic products 11, 12, and 17, respectively, resulting from double Bingel addition to one C-sphere. Rigorous analysis revealed that this novel macrocyclization reaction proceeds with complete regio- and diastereoselectivity. The second approach to a suitable PTA monomer attempted N,N′-dicyclohexylcarbodiimide(DCC)-mediated esterification of (E)-2,3-diethynylbut-2-ene-1,4-diol (18, Scheme 6) with mono-esterified methanofullerene-dicarboxylic acid 23; however, this synthesis yielded only the corresponding decarboxylated methanofullerene-carboxylic ester 27 (Scheme 7). To prevent decarboxylation, a spacer was inserted between the reacting carboxylic-acid moiety and the methano C-atom in carboxymethyl ethyl 1,2-methano[60]fullerene-61,61-dicarboxylate (28, Scheme 8), and DCC-mediated esterification with diol 18 afforded PTA monomer 32 in good yield. The formation of a suitable monomeric precursor 38 to C60-substituted expanded radialenes was achieved in 5 steps starting from dihydroxyacetone (Schemes 9 and 10), with the final step consisting of the DCC-mediated esterification of 28 with 2-[1-ethynyl(prop-2-ynylidene)]propane-1,3-diol (33). The first mixed C60-C70 fullerene derivative 49, consisting of two methano[60]fullerenes attached to a methano[70]fullerene, was also prepared and fully characterized (Scheme 13). The Cs-symmetrical hybrid compound was obtained by DCC-mediated esterification of bis[2-(2-hydroxyethoxy)ethyl] 1,2-methano[70]fullerene-71,71-dicarboxylate (46) with an excess of the C60-carboxylic acid 28. The presence of two different fullerenes in the same molecule was reflected by its UV/VIS spectrum, which displayed the characteristic absorption bands of both the C70 and C60 mono-adducts, but at the same time indicated no electronic interaction between the different fullerene moieties. Cyclic voltammetry showed two reversible reduction steps for 49, and comparison with the corresponding C70 and C60 mono-adducts 46 and 30 indicated that the three fullerenes in the composite fullerene compound behave as independent redox centers.

Size-selective mesoporous silica-based Pt(II)complex as efficient and reusable photocatalytic material

González-Mu?oz, Daniel,Casado-Sánchez, Antonio,del Hierro, Isabel,Gómez-Ruiz, Santiago,Cabrera, Silvia,Alemán, José

, p. 374 - 383 (2019/05/01)

The grafting of a Pt(II)photocatalyst into three different mesoporous silica-based materials with different particle sizes and pore sizes was easily achieved through an amide bond formation. The analysis and results of the different characterization techniques showed that the catalyst is immobilized inside the pores of the materials and the photophysical properties of the catalyst are preserved after the covalent anchoring. The photocatalytic material catalyzed efficiently the debromination reaction of different substrates and is reused without detriment in its catalytic activity. In addition, the incorporation of the catalyst into mesoporous silica materials with different pore size allows the selective debromination of substrates by size discrimination.

Process for preparing C5 products and their use for Atorvastatin synthesis

-

Page/Page column 17, (2010/11/23)

The present invention relates to a process for preparing C5 intermediates and their use in the preparation of pyrrole derivatives of a class that is effective at inhibiting the biosynthesis of cholesterol in humans, and more particularly to improved synthetic methods for preparing 3,5-dihydroxy-7-pyrrol-1-yl heptanoic acids from 1,4-diketo starting materials. The invention further relates to intermediates in this process

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 541-16-2